Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Operating Income (QoQ) (2009 - 2026)

Analysis

Edwards Lifesciences (EW) Operating Income (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.45%
Mar 31, 2026 216.08%
Dec 31, 2025 -50.80%
Sep 30, 2025 -25.32%
Jun 30, 2025 4.15%
Mar 31, 2025 26.30%
Dec 31, 2024 -10.84%
Sep 30, 2024 -4.34%
Jun 30, 2024 5.01%
Mar 31, 2024 0.63%
Dec 31, 2023 -5.22%
Sep 30, 2023 38.86%
Jun 30, 2023 -32.16%
Mar 31, 2023 96.46%
Dec 31, 2022 -50.87%
Sep 30, 2022 -12.43%
Jun 30, 2022 4.72%
Mar 31, 2022 17.20%
Dec 31, 2021 -4.07%
Sep 30, 2021 -28.00%